DPP4 and leukemia: As shown in Figure 2A–E, triptolide showed dose-dependent cytotoxic effects against the MM cell lines MSTO-wt, MSTO-clone12, JMN, and leukemia cell lines Jurkat, Jurkat CD26(+) after 48 h of treatment in WST-1 assays.